IRCT20180201038585N5CompletedPhase 3
The effect of vitamin B1 (thiamine) on blood pressure, lipid profile, liver enzymes and fasting blood sugar in patients with metabolic syndrome
Bagheiat-allah University of Medical Sciences0 sites116 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 116
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 25 years to 50 years (—)
- Sex
- All
Inclusion Criteria
- •age: 25 -50 years
- •Military personnel with metabolic syndrome
Exclusion Criteria
- •Having a history of cardiovascular
- •disease morbility liver, kidney
- •Consumption alcoho, smoking ,supplementation and certain drugs
- •People who during the study less than 80% of the tablets vitamin b1 and placebo to consume.
Investigators
Similar Trials
Completed
Phase 2
Vitamin B1 (thiamine) administration in enterally-fed critically ill patients with hypophosphatemia: A prospective, randomised clinical trialHypophosphatemiaCritical illnessenteral nutritionMetabolic and Endocrine - Other metabolic disordersDiet and Nutrition - Other diet and nutrition disordersThiamine deficiencyACTRN12619000121167Royal Melbourne Hospital90
Recruiting
Phase 3
The protective effect of Thiamine (vitamin B1) for Bortezomib induced peripheral neuropathy in multiple myelomaneuropathy.IRCT20190116042379N1Esfahan University of Medical Sciences58
Not yet recruiting
Phase 3
The effect of high-dose of vitamin B1 supplementation on episodic migraine in womeMigraineIRCT20140804018677N24Shahid Beheshti University of Medical Sciences, Nutrition and Food Industries Research Institute40
Completed
Phase 2
Thiamine supplementation in type 2 diabetesType 2 diabetes mellitusNutritional, Metabolic, EndocrineNon-insulin-dependent diabetes mellitusISRCTN30703970Portsmouth Hospitals NHS Trust (UK)34
Active, not recruiting
Not Applicable
Oral thiamine (Vitamin B1) supplementation in subjects with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled crossover trial assessing biophysical markers of endothelial function, oxidant stress, insulin sensitivity and vascular inflammation - Thiamine supplementation in type 2 diabetes.Type 2 diabetesEUCTR2009-017537-21-GBPortsmouth Hospitals NHS Trust34